Parasomnias (Parasomnia)

Subscribe to Selected New Research on Parasomnias

39 relevant articles (2 outcomes, 2 trials/studies) found for this Disease

Description: Movements or behaviors associated with sleep, sleep stages, or partial arousals from sleep that may impair sleep maintenance. Parasomnias are generally divided into four groups: arousal disorders, sleep-wake transition disorders, parasomnias of REM sleep, and nonspecific parasomnias. (From Thorpy, Sleep Disorders Medicine, 1994, p191)

Also Known As:

Parasomnia; Benign Neonatal Sleep Myoclonus; Myoclonus, Benign Neonatal Sleep; Sensory Paroxysms, Sleep; Sleep-Related Abnormal Swallowing Syndrome; Drunkenness, Sleep; Drunkennesses, Sleep; Paroxysm, Sleep Sensory; Paroxysms, Sleep Sensory; Sensory Paroxysm, Sleep; Sleep Drunkennesses; Sleep Related Abnormal Swallowing Syndrome; Sleep Sensory Paroxysm; Sleep Sensory Paroxysms; Neonatal Sleep Myoclonus, Benign; Sleep Drunkenness

Relationship Network

Disease Context: Research Results

Nervous System Diseases: 3406

Sleep Disorders: 650

Parasomnias: 39

Restless Legs Syndrome: 498

Sleep Bruxism: 52

Sleep-Wake Transition Disorders: 42

Nocturnal Myoclonus Syndrome: 22

Nocturnal Paroxysmal Dystonia: 14

Sleep Arousal Disorders: 4

REM Sleep Parasomnias

Mental Disorders: 1707

Sleep Disorders: 650

Parasomnias: 39

Restless Legs Syndrome: 498

Sleep Bruxism: 52

Sleep-Wake Transition Disorders: 42

Nocturnal Paroxysmal Dystonia: 14

Sleep Arousal Disorders: 4

REM Sleep Parasomnias

Related Diseases

1.	Night Terrors (Sleep Terror)
2.	Somnambulism (Sleepwalking)
3.	Narcolepsy
4.	Sleep Initiation and Maintenance Disorders (Insomnia)
5.	Syndrome

Experts

1.	Walters, Arthur S: 1 article (05/2008)
2.	Siddiqui, Fouzia: 1 article (05/2008)
3.	Chokroverty, Sudhansu: 1 article (05/2008)
4.	Boeve, Bradley F: 1 article (06/2007)
5.	Silber, Michael H: 1 article (06/2007)
6.	Hauri, Peter J: 1 article (06/2007)
7.	Partinen, M: 1 article (06/2001)
8.	Hublin, C: 1 article (06/2001)
9.	Kaprio, J: 1 article (06/2001)
10.	Koskenvu, M: 1 article (06/2001)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Parasomnias:

1.	Clonazepam (Rivotril)FDA LinkGeneric 07/01/2002 - "Clonazepam was administered for parasomnia in 3 cases with a favorable response" 06/01/2007 - "Bedtime clonazepam therapy was effective in 90% (9/10) of treated parasomnia cases; nasal continuous positive airway pressure therapy was effective in controlling comorbid OSA and CAs in both treated cases" 06/01/1995 - "Case 2, a 46-year-old woman without psychiatric disorder, presented with a 5-year history of sleep terrors and injurious sleep-walking that initially was not menstrually related, but beginning 8 months prior to referral, she developed an exclusively premenstrual parasomnia that, after polysomnography, was partially controlled with bedtime self-hypnosis and clonazepam, 0.25 mg." 11/01/1997 - "Treatment outcome was available for n = 20 patients; 90% (n = 18) had substantial parasomnia control with bedtime clonazepam (n = 13), alprazolam and/or carbamazepine (n = 4), or self-hypnosis (n = 1)" Order ALL the reference details at left...
2.	Hypnotics and Sedatives (Sedatives)IBA 09/01/1997 - "The prevalences of various sleep symptoms including insomnia, daytime tiredness, fatigue, parasomnias and the use of hypnotics remained similar in the same age cohorts during economic recession" 08/01/1999 - "They were requested to answer a questionnaire newly designed for this study, which consisted of 34 questions concerning sociodemographic characteristics, current medical conditions, sleep habits, current or past sleep complaints, symptoms of parasomnia, use of hypnotics/anxiolytics and other aspects of daily life" Order ALL the reference details at left...
3.	Anti-Anxiety Agents (Anxiolytics)IBA 08/01/1999 - "They were requested to answer a questionnaire newly designed for this study, which consisted of 34 questions concerning sociodemographic characteristics, current medical conditions, sleep habits, current or past sleep complaints, symptoms of parasomnia, use of hypnotics/anxiolytics and other aspects of daily life" Order ALL the reference details at left...
4.	Carbon MonoxideIBA 12/01/2003 - "various parasomnias, sleep-related anxiety) illustrates the need for a holistic approach to assessment since these co-existing SD can be the most overt symptoms" 12/01/2001 - "This article provides a brief review of the recent literature regarding parasomnias, and a clinically oriented approach to the management of parasomnias in patients with co-existing clinical disorders." 12/01/2001 - "In patients with co-existing clinical disorders, parasomnias need to be distinguished from symptoms of the underlying disorder" 06/01/2001 - "In clinical practice, parasomnias are often found to run in families and to co-occur" 06/01/2001 - "Parasomnias: co-occurrence and genetics." Order ALL the reference details at left...
5.	MelatoninIBA 12/01/2001 - "This article focuses on the following specific neurologic diseases: nocturnal frontal lobe epilepsy and abnormal motor behaviors of epileptic origin, evaluating differential diagnosis with parasomnias; achondroplasia, confirming the crucial role of craniofacial deformity in determining sleep-disordered breathing; neuromuscular diseases, mainly Duchenne's muscular dystrophy and myotonic dystrophy; cerebral palsy, evaluating either the features of sleep architecture and the importance of the respiratory problems associated; headaches, confirming the strict relationships with sleep in terms of neurochemical and neurobehavioral substrates; and finally a review on the effectiveness of melatonin for sleep problems in children with neurologic syndromes and mental retardation, blindness, and epilepsy." 02/01/2005 - "The median percentage decrease in the parasomnias score was 60 (range 0.0-70.8) in the valproate + melatonin group compared with 36.4 (range 0.0-63.2) in the valproate + placebo group, the difference being statistically significant (P < .05)" Order ALL the reference details at left...
6.	tebufenozide (Mimic)IBA 05/01/2008 - "Catathrenia: a rare parasomnia which may mimic central sleep apnea on polysomnogram." 12/01/2008 - "Sleep terrors, confusional arousals and sleepwalking may mimic seizures; distinguishing seizures from parasomnias is discussed" Order ALL the reference details at left...
7.	mofezolac (N 22)IBA 11/01/2008 - "MATERIAL AND METHODS: The FSS was administered to 454 healthy subjects, 188 patients with multiple sclerosis (MS), 235 patients with recent ischemic stroke, and 429 patients with sleep-wake disorders including narcolepsy with cataplexy (n=22), restless legs syndrome (RLS) (n=79), sleep apnea (n=108), insomnia (n=62), parasomnia (n=25), excessive daytime sleepiness/hypersomnia of other origin (n=84, and other sleep-wake disorders (n=49" 11/01/1997 - "An idiopathic subgroup (n = 22) had a significantly earlier mean age of parasomnia onset (9 +/- 7 years) than a symptomatic subgroup (n = 11) (27 +/- 23 years, p = 0.002), whose parasomnia began with either of the following: neurologic disorders, n = 6 [congenital Mobius syndrome, narcolepsy, multiple sclerosis, brain tumor (and treatment), brain trauma, indeterminate disorder (exaggerated startle response/atypical cataplexy)]; nocturnal paroxysmal atrial fibrillation, n = 1; posttraumatic stress disorder/major depression, n = 1; chronic ethanol/amphetamine abuse and withdrawal, n = 1; or mixed disorders (schizophrenia, brain trauma, substance abuse), n = 2. The rate of DSM-III-R (Diagnostic and Statistical Manual, 3rd edition, revised) Axis 1 psychiatric disorders was not elevated; group scores on various psychometric tests were not elevated" Order ALL the reference details at left...
8.	neodymium pyrocatechin disulfonate (NPD)IBA 06/01/1994 - "The considerable similarity of the clinical and paraclinical signs and of the effects of anti-epileptic treatments do not seem to justify the individualization of different subgroups as a function of the EEG patterns: the NPD are always the result of focal epilepsy, and never of a pathology of movement or of parasomnia" 03/01/2000 - "Some authors consider it as a type of parasomnia, akin to night terrors and the official Classification of Sleep Disorder includes NPD within the parasomnias [1]" Order ALL the reference details at left...
9.	Citalopram (Escitalopram)FDA LinkGeneric 01/01/2008 - "The parasomnia disappeared on the sixth day after the escitalopram had been stopped" 01/01/2008 - "A 30-year-old man, with no history of parasomnias or related precipitating factors, developed sexual behaviour during sleep after three weeks of treatment with escitalopram 10 mg daily" Order ALL the reference details at left...
10.	Valproic Acid (Valproate, Semisodium)FDA LinkGeneric 02/01/2005 - "The median percentage decrease in the parasomnias score was 60 (range 0.0-70.8) in the valproate + melatonin group compared with 36.4 (range 0.0-63.2) in the valproate + placebo group, the difference being statistically significant (P < .05)" Order ALL the reference details at left...

Therapies and Procedures

1.	Hypnosis (Mesmerism) 06/15/2007 - "STUDY OBJECTIVES: This study involves a replication and extension of a previous one reported by Hurwitz et al (1991) on the treatment of certain parasomnias with hypnosis" 06/15/2007 - "The treatment of parasomnias with hypnosis: a 5-year follow-up study." 02/01/2001 - "Arousal parasomnias can be treated with behavioral methods such as hypnosis and drug therapy" 04/01/1991 - "Hypnosis has been described anecdotally to be effective in the treatment of sleepwalking and sleep terror, potentially dangerous parasomnias" 06/01/1995 - "Case 2, a 46-year-old woman without psychiatric disorder, presented with a 5-year history of sleep terrors and injurious sleep-walking that initially was not menstrually related, but beginning 8 months prior to referral, she developed an exclusively premenstrual parasomnia that, after polysomnography, was partially controlled with bedtime self-hypnosis and clonazepam, 0.25 mg." Order ALL the reference details at left...
2.	Continuous Positive Airway Pressure 04/01/2005 - "Polysomnography is routinely indicated for the diagnosis of sleep related breathing disorders; for continuous positive airway pressure (CPAP) titration in patients with sleep related breathing disorders; for the assessment of treatment results in some cases; with a multiple sleep latency test in the evaluation of suspected narcolepsy; in evaluating sleep related behaviors that are violent or otherwise potentially injurious to the patient or others; and in certain atypical or unusual parasomnias" 01/01/2003 - "Important innovations include the expansion of BSM beyond the treatment of insomnia to include treatment of pediatric sleep disorders, circadian rhythm disorders, parasomnias, as well as desensitization procedures for patients undergoing treatment with nasal continuous positive airway pressure (CPAP)." 06/01/1997 - "Polysomnography is routinely indicated for the diagnosis of sleep-related breathing disorders; for continuous positive airway pressure (CPAP) titration in patients with sleep-related breathing disorders; for documenting the presence of obstructive sleep apnea in patients prior to laser-assisted uvulopalatopharyngoplasty; for the assessment of treatment results in some cases; with a multiple sleep latency test in the evaluation of suspected narcolepsy; in evaluating sleep-related behaviors that are violent or otherwise potentially injurious to the patient or others; and in certain atypical or unusual parasomnias" 06/01/2007 - "Bedtime clonazepam therapy was effective in 90% (9/10) of treated parasomnia cases; nasal continuous positive airway pressure therapy was effective in controlling comorbid OSA and CAs in both treated cases" Order ALL the reference details at left...
3.	Lasers (Laser) 06/01/1997 - "Polysomnography is routinely indicated for the diagnosis of sleep-related breathing disorders; for continuous positive airway pressure (CPAP) titration in patients with sleep-related breathing disorders; for documenting the presence of obstructive sleep apnea in patients prior to laser-assisted uvulopalatopharyngoplasty; for the assessment of treatment results in some cases; with a multiple sleep latency test in the evaluation of suspected narcolepsy; in evaluating sleep-related behaviors that are violent or otherwise potentially injurious to the patient or others; and in certain atypical or unusual parasomnias" Order ALL the reference details at left...
4.	Drug Therapy (Chemotherapy) 02/01/2001 - "Arousal parasomnias can be treated with behavioral methods such as hypnosis and drug therapy" Order ALL the reference details at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>